Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Perampanel is an aryl substituted 2-pyridone AMPA receptor antagonist that was recently approved as a treatment for epilepsy. The drug potently inhibits AMPA receptor responses but the mode of block has not been characterized. Here the action of perampanel on AMPA receptors was investigated by whole-cell voltage-clamp recording in cultured rat hippocampal neurons. Perampanel caused a slow (∼1 s at 3 μM), concentration-dependent inhibition of AMPA receptor currents evoked by AMPA and kainate. The rates of block and unblock of AMPA receptor currents were105M-1s-1and 0.58 s-1, respectively. Perampanel did not affect NMDA receptor currents. The extent of block of non-desensitizing kainate-evoked currents (IC50, 0.56 μM) was similar at all kainate concentrations (3-100 μM), demonstrating a noncompetitive blocking action. Parampanel did not alter the trajectory of AMPA evoked currents indicating that it does not influence AMPA receptor desensitization. Perampanel is a selective negative allosteric AMPA receptor antagonist of high-affinity and slow blocking kinetics.

Original languageEnglish (US)
Article numberA1249
JournalPLoS One
Issue number9
StatePublished - Sep 17 2014

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)


Dive into the research topics of 'Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons'. Together they form a unique fingerprint.

Cite this